Current Neuro-Oncology




Volume 12 Number 12
31 December 2010




Home > Publications > Current Neuro-Oncology > Volume 12, Year 2010 > Number 12, 31 December




Chang WS, Kim HY, Chang JW, Park YG, Chang JH.
Analysis of radiosurgical results in patients with brain metastases according to the number of brain lesions: is stereotactic radiosurgery effective for multiple brain metastases? Clinical article.
J Neurosurg. 2010 Dec;113 Suppl:73-8. doi: 10.3171/2010.8.GKS10994
PMID: 21121789 Retrospective analysis.




Liang CL, Lu K, Liliang PC, Chen HJ.
Gamma Knife surgery for optic glioma. Report of 2 cases.
J Neurosurg. 2010 Dec;113 Suppl:44-7. doi: 10.3171/2010.7.GKS10945
PMID: 21121786 Case series;




Liu D, Xu D, Zhang Z, Zhang Y, Li Y, Liu X, Jia Q, Zheng L, Song G.
Long-term results of Gamma Knife surgery for optic nerve sheath meningioma. Clinical article.
J Neurosurg. 2010 Dec;113 Suppl:28-33. doi: 10.3171/2010.7.GKS10869
PMID: 21121784 Retrospective analysis.




Gilman AL, Jacobsen C, Bunin N, Levine J, Goldman F, Bendel A, Joyce M, Anderson P, Rozans M, Wall DA, Macdonald TJ, Simon S, Kadota RP.
Phase I study of tandem high-dose chemotherapy with autologous peripheral blood stem cell rescue for children with recurrent brain tumors: A pediatric blood and marrow transplant consortium study.
Pediatr Blood Cancer. 2010 Dec 1. 2011 Sep;57(3):506-13. doi: 10.1002/pbc.22899 PMID: 21744474 Phase 1 trial.




Nowosielski M, Recheis W, Goebel G, Güler O, Tinkhauser G, Kostron H, Schocke M, Gotwald T, Stockhammer G, Hutterer M.
ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma.
Neuroradiology. 2010 Dec 2. 2011;53(4):291-302. doi: 10.1007/s00234-010-0808-0
PMID: 21125399 Retrospective analysis.




Hasegawa T, Kida Y, Yoshimoto M, Iizuka H, Ishii D, Yoshida K.
Gamma Knife surgery for convexity, parasagittal, and falcine meningiomas.
J Neurosurg. 2010 Dec 3. 2011;114(5):1392-8. doi: 10.3171/2010.11.JNS10112
PMID: 21128736 Retrospective analysis.




Gore EM, Bae K, Wong SJ, Sun A, Bonner JA, Schild SE, Gaspar LE, Bogart JA, Werner-Wasik M, Choy H.
Phase III Comparison of Prophylactic Cranial Irradiation Versus Observation in Patients With Locally Advanced Non-Small-Cell Lung Cancer: Primary Analysis of Radiation Therapy Oncology Group Study RTOG 0214.
J Clin Oncol. 2010 Dec 6. 2011;29(3):272-8. doi: 10.1200/JCO.2010.29.1609
PMID: 21135270 Phase 3 trial.




Lai A, Tran A, Nghiemphu PL, Pope WB, Solis OE, Selch M, Filka E, Yong WH, Mischel PS, Liau LM, Phuphanich S, Black K, Peak S, Green RM, Spier CE, Kolevska T, Polikoff J, Fehrenbacher L, Elashoff R, Cloughesy T.
Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme.
J Clin Oncol. 2010 Dec 6. 2011;29(2):142-8. doi: 10.1200/JCO.2010.30.2729
PMID: 21135282 Phase 2 trial.




Wong ET, Brem S.
Taming glioblastoma by targeting angiogenesis: 3 years later.
J Clin Oncol. 2010 Dec 6. 2011;29(2):124-6. doi: 10.1200/JCO.2010.32.5282
PMID: 21135277 Comment.
Lai A, et al.
Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme.
J Clin Oncol. 2010 Dec 6. 2011;29(2):142-8. doi: 10.1200/JCO.2010.30.2729
PMID: 21135282 Phase 2 trial.




Katchy KC, Mallik AA, Al-Nashmi NM, Joseph E, Alexander S, Al-Ramadan A.
Intracranial tumors in Kuwait: a 15-year survey.
J Neurooncol. 2010 Dec 7. 2011;104(1):271-7. doi: 10.1007/s11060-010-0482-4
PMID: 21136281 Epidemiology analysis.




Gibson P, Tong Y, Robinson G, Thompson MC, Currle DS, Eden C, Kranenburg TA, Hogg T, Poppleton H, Martin J, Finkelstein D, Pounds S, Weiss A, Patay Z, Scoggins M, Ogg R, Pei Y, Yang ZJ, Brun S, Lee Y, Zindy F, Lindsey JC, Taketo MM, Boop FA, Sanford RA, Gajjar A, Clifford SC, Roussel MF, McKinnon PJ, Gutmann DH, Ellison DW, Wechsler-Reya R, Gilbertson RJ.
Subtypes of medulloblastoma have distinct developmental origins.
Nature. 2010 Dec 8;468(7327):1095-9
. doi: 10.1038/nature09587. PMID: 21150899. Laboratory investigation.




Jaeckle KA, Decker PA, Ballman KV, Flynn PJ, Giannini C, Scheithauer BW, Jenkins RB, Buckner JC.
Transformation of low grade glioma and correlation with outcome: an NCCTG database analysis.
J Neurooncol. 2010 Dec 12. 2011;104(1):253-9. doi: 10.1007/s11060-010-0476-2
PMID: 21153680 Prospective study.




Bedikian AY, Wei C, Detry M, Kim KB, Papadopoulos NE, Hwu WJ, Homsi J, Davies M, McIntyre S, Hwu P.
Predictive Factors for the Development of Brain Metastasis in Advanced Unresectable Metastatic Melanoma.
Am J Clin Oncol. 2010 Dec 13. 2011;34(6):603-10. doi: 10.1097/COC.0b013e3181f9456a
PMID: 21150567 Retrospective analysis.




Etcheverry A, Aubry M, Tayrac MD, Vauleon E, Boniface R, Guenot F, Saikali S, Hamlat A, Riffaud L, Menei P, Quillien V, Mosser J.
DNA methylation in glioblastoma: impact on gene expression and clinical outcome.
BMC Genomics. 2010 Dec 14;11(1):701. doi: 10.1186/1471-2164-11-701
PMID: 21156036 Laboratory investigation.




Lu-Emerson C, Norden AD, Drappatz J, Quant EC, Beroukhim R, Ciampa AS, Doherty LM, Lafrankie DC, Ruland S, Wen PY.
Retrospective study of dasatinib for recurrent glioblastoma after bevacizumab failure.
J Neurooncol. 2010 Dec 14. 2011;104(1):287-91. doi: 10.1007/s11060-010-0489-x
PMID: 21153679 Retrospective analysis.




Pei Y, Wechsler-Reya RJ.
A Malignant Oligarchy: Progenitors Govern the Behavior of Oligodendrogliomas.
Cancer Cell. 2010 Dec 14;18(6):546-7. doi: 10.1016/j.ccr.2010.11.031
PMID: 21156279 Comment.
Persson AI, et al.
Non-Stem Cell Origin for Oligodendroglioma.
Cancer Cell. 2010 Dec 14;18(6):669-82. doi: 10.1016/j.ccr.2010.10.033
PMID: 21156288 Laboratory investigation.




Persson AI, Petritsch C, Swartling FJ, Itsara M, Sim FJ, Auvergne R, Goldenberg DD, Vandenberg SR, Nguyen KN, Yakovenko S, Ayers-Ringler J, Nishiyama A, Stallcup WB, Berger MS, Bergers G, McKnight TR, Goldman SA, Weiss WA.
Non-Stem Cell Origin for Oligodendroglioma.
Cancer Cell. 2010 Dec 14;18(6):669-82. doi: 10.1016/j.ccr.2010.10.033
PMID: 21156288 Laboratory investigation.




Xu Z, Yen CP, Schlesinger D, Sheehan J.
Outcomes of Gamma Knife surgery for craniopharyngiomas.
J Neurooncol. 2010 Dec 14. 2011;104(1):305-13. doi: 10.1007/s11060-010-0494-0
PMID: 21153860 Retrospective analysis.




Mathiesen T, Peredo I, Lönn S.
Two-year survival of low-grade and high-grade glioma patients using data from the Swedish Cancer Registry.
Acta Neurochir (Wien). 2010 Dec 15. 2011;153(3):467-71. doi: 10.1007/s00701-010-0894-0
PMID: 21161295 Retrospective analysis.




Narayana A, Kunnakkat SD, Medabalmi P, Golfinos J, Parker E, Knopp E, Zagzag D, Eagan P, Gruber D, Gruber ML.
Change in Pattern of Relapse After Antiangiogenic Therapy in High-Grade Glioma.
Int J Radiat Oncol Biol Phys. 2010 Dec 15. 2012;82(1):77-82. doi: 10.1016/j.ijrobp.2010.10.038
PMID: 21163583 Retrospective analysis.




Rapp M, Felsberg J, Sorg RV, Gerharz CD, Sabel M.
Case report: extracranial metastasis from gliosarcoma - the influence of immune system.
Br J Neurosurg. 2010 Dec 15. 2011;25(2):286-8. doi: 10.3109/02688697.2010.528473
PMID: 21158519 Case report.




Parsons DW, Li M, Zhang X, Jones S, Leary RJ, Lin JC, Boca SM, Carter H, Samayoa J, Bettegowda C, Gallia GL, Jallo GI, Binder ZA, Nikolsky Y, Hartigan J, Smith DR, Gerhard DS, Fults DW, VandenBerg S, Berger MS, Marie SK, Shinjo SM, Clara C, Phillips PC, Minturn JE, Biegel JA, Judkins AR, Resnick AC, Storm PB, Curran T, He Y, Rasheed BA, Friedman HS, Keir ST, McLendon R, Northcott PA, Taylor MD, Burger PC, Riggins GJ, Karchin R, Parmigiani G, Bigner DD, Yan H, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE.
The genetic landscape of the childhood cancer medulloblastoma.
Science. 2010 Dec 16. 2011;331(6016):435-9
. doi: 10.1126/science.1198056. PMID: 21163964. Laboratory investigation.




Hardell L, Carlberg M, Hansson Mild K.
Re-analysis of risk for glioma in relation to mobile telephone use: comparison with the results of the Interphone international case-control study.
Int J Epidemiol. 2010 Dec 17. 2011;40(4):1126-8. doi: 10.1093/ije/dyq246
PMID: 21169317 Comment.
Interphone study group. Cardis E, et al.
Brain tumour risk in relation to mobile telephone use: results of the Interphone international case-control study.
Int J Epidemiol. 2010 May 17. 2010;39(3):675-94. doi: 10.1093/ije/dyq079
PMID: 20483835 Epidemiology analysis.
Int J Epidemiol. 2011 Dec 13. 2012;41(1):328.
doi:10.1093/ije/dyr192 Correction.




Interphone study group. Cardis E, et al.
Brain tumour risk in relation to mobile telephone use: results of the Interphone international case-control study.
Int J Epidemiol. 2010 May 17. 2010;39(3):675-94. doi: 10.1093/ije/dyq079
PMID: 20483835 Epidemiology analysis.
Int J Epidemiol. 2011 Dec 13. 2012;41(1):328. doi:10.1093/ije/dyr192 Correction.




Taal W, Dubbink HJ, Zonnenberg CB, Zonnenberg BA, Postma TJ, Gijtenbeek JM, Boogerd W, Groenendijk FH, Kros JM, Kouwenhoven MC, van Marion R, van Heuvel I, van der Holt B, Bromberg JE, Sillevis Smitt PA, Dinjens WN, van den Bent MJ; Dutch Society for Neuro-Oncology.
First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response.
Neuro Oncol. 2010 Dec 21. 2011;13(2):235-41. doi: 10.1093/neuonc/noq177
. PMID: 21177338. Retrospective analysis.




Armstrong GT, Conklin HM, Huang S, Srivastava D, Sanford R, Ellison DW, Merchant TE, Hudson MM, Hoehn ME, Robison LL, Gajjar A, Morris EB.
Survival and long-term health and cognitive outcomes after low-grade glioma.
Neuro Oncol. 2010 Dec 22. 2011;13(2):223-34. doi: 10.1093/neuonc/noq178
PMID: 21177781 Retrospective analysis.




Bredel M, Scholtens DM, Yadav AK, Alvarez AA, Renfrow JJ, Chandler JP, Yu IL, Carro MS, Dai F, Tagge MJ, Ferrarese R, Bredel C, Phillips HS, Lukac PJ, Robe PA, Weyerbrock A, Vogel H, Dubner S, Mobley B, He X, Scheck AC, Sikic BI, Aldape KD, Chakravarti A, Harsh GR.
NFKBIA Deletion in Glioblastomas.
N Engl J Med. 2010 Dec 22. 2011;364(7):627-37. doi: 10.1056/NEJMoa1006312
PMID: 21175304 Laboratory investigation.




Broadley KW, Hunn MK, Farrand KJ, Price KM, Grasso C, Miller RJ, Hermans IF, McConnell MJ.
Side Population is not Necessary or Sufficient for a Cancer Stem Cell Phenotype in Glioblastoma Multiforme.
Stem Cells. 2010 Dec 23. 2011;29(3):452-61. doi: 10.1002/stem.582
PMID: 21425408 Laboratory investigation.




Takahashi K, Nishihara H, Katoh M, Yoshinaga T, Mahabir R, Kanno H, Kimura T, Tanino M, Ikeda J, Sawamura Y, Nagashima K, Tanaka S.
A case of atypical teratoid/rhabdoid tumor in an adult, with long survival.
Brain Tumor Pathol. 2010 Dec 23. 2011;28(1):71-6. doi: 10.1007/s10014-010-0008-y
PMID: 21181449 Case report.




Christensen K, Schrøder HD, Kristensen BW.
CD133(+) niches and single cells in glioblastoma have different phenotypes.
J Neurooncol. 2010 Dec 24. 2011;104(1):129-43. doi: 10.1007/s11060-010-0488-y
PMID: 21184132 Laboratory investigation.




Janic A, Mendizabal L, Llamazares S, Rossell D, Gonzalez C.
Ectopic expression of germline genes drives malignant brain tumor growth in Drosophila.
Science. 2010 Dec 24;330(6012):1824-7. doi: 10.1126/science.1195481
PMID: 21205669 Laboratory investigation.